Carcinoma in situ of bladder (disorder)

BOXIT-T is the translational arm of the BOXIT randomised double-blind placebo-controlled trial evaluating the addition of celecoxib, a COX-2 inhibitor, to standard therapy for high and intermediate risk non-invasive bladder cancer.

Year Started: 2007

Paraffin embedded tissue, Fresh tissue, Blood samples, Urine samples



Access:
Open to applicants
Type:
Clinical Trial
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
There is no associated data for this collection.


Unknown

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
There are no material preservation details for this sample set